HYGIEIA : HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach
More than two years on, the COVID-19 pandemic continues to wreak havoc around the world and has battle-tested the pandemic-situation responses of all major global governments. Two key areas of investigation that are still unclear are: the molecular mechanisms that lead to heterogenic patient outcomes, and the causes of Post COVID condition (AKA Long-COVID). In this paper, we introduce the HYGIEIA project, designed to respond to the enormous challenges of the COVID-19 pandemic through a multi-omic approach supported by network medicine. It is hoped that in addition to investigating COVID-19, the logistics deployed within this project will be applicable to other infectious agents, pandemic-type situations, and also other complex, non-infectious diseases. Here, we first look at previous research into COVID-19 in the context of the proteome, metabolome, transcriptome, microbiome, host genome, and viral genome. We then discuss a proposed methodology for a large-scale multi-omic longitudinal study to investigate the aforementioned biological strata through high-throughput sequencing (HTS) and mass-spectrometry (MS) technologies. Lastly, we discuss how a network medicine approach can be used to analyze the data and make meaningful discoveries, with the final aim being the translation of these discoveries into the clinics to improve patient care.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Viruses - 14(2022), 7 vom: 23. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ward, Bradley [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 28.07.2022 Date Revised 07.12.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/v14071373 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344111458 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344111458 | ||
| 003 | DE-627 | ||
| 005 | 20231226022015.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/v14071373 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1146.xml |
| 035 | |a (DE-627)NLM344111458 | ||
| 035 | |a (NLM)35891354 | ||
| 035 | |a (PII)1373 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ward, Bradley |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HYGIEIA |b HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.07.2022 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a More than two years on, the COVID-19 pandemic continues to wreak havoc around the world and has battle-tested the pandemic-situation responses of all major global governments. Two key areas of investigation that are still unclear are: the molecular mechanisms that lead to heterogenic patient outcomes, and the causes of Post COVID condition (AKA Long-COVID). In this paper, we introduce the HYGIEIA project, designed to respond to the enormous challenges of the COVID-19 pandemic through a multi-omic approach supported by network medicine. It is hoped that in addition to investigating COVID-19, the logistics deployed within this project will be applicable to other infectious agents, pandemic-type situations, and also other complex, non-infectious diseases. Here, we first look at previous research into COVID-19 in the context of the proteome, metabolome, transcriptome, microbiome, host genome, and viral genome. We then discuss a proposed methodology for a large-scale multi-omic longitudinal study to investigate the aforementioned biological strata through high-throughput sequencing (HTS) and mass-spectrometry (MS) technologies. Lastly, we discuss how a network medicine approach can be used to analyze the data and make meaningful discoveries, with the final aim being the translation of these discoveries into the clinics to improve patient care | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a genomics | |
| 650 | 4 | |a metabolomics | |
| 650 | 4 | |a metagenomics | |
| 650 | 4 | |a network medicine | |
| 650 | 4 | |a post COVID condition | |
| 650 | 4 | |a proteomics | |
| 650 | 4 | |a transcriptomics | |
| 700 | 1 | |a Yombi, Jean Cyr |e verfasserin |4 aut | |
| 700 | 1 | |a Balligand, Jean-Luc |e verfasserin |4 aut | |
| 700 | 1 | |a Cani, Patrice D |e verfasserin |4 aut | |
| 700 | 1 | |a Collet, Jean-François |e verfasserin |4 aut | |
| 700 | 1 | |a de Greef, Julien |e verfasserin |4 aut | |
| 700 | 1 | |a Dewulf, Joseph P |e verfasserin |4 aut | |
| 700 | 1 | |a Gatto, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Haufroid, Vincent |e verfasserin |4 aut | |
| 700 | 1 | |a Jodogne, Sébastien |e verfasserin |4 aut | |
| 700 | 1 | |a Kabamba, Benoît |e verfasserin |4 aut | |
| 700 | 1 | |a Pyr Dit Ruys, Sébastien |e verfasserin |4 aut | |
| 700 | 1 | |a Vertommen, Didier |e verfasserin |4 aut | |
| 700 | 1 | |a Elens, Laure |e verfasserin |4 aut | |
| 700 | 1 | |a Belkhir, Leïla |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Viruses |d 2009 |g 14(2022), 7 vom: 23. Juni |w (DE-627)NLM192382764 |x 1999-4915 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2022 |g number:7 |g day:23 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/v14071373 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2022 |e 7 |b 23 |c 06 | ||